Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Secondary Immunodeficiency”

103 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 103 results

Not applicableUnknownNCT05727033
What this trial is testing

Extraordinarily Fun Training Project in Compulsory Secondary Education - Sexually Transmitted Infections

Who this might be right for
Chlamydia InfectionsGonorrheaSyphilis Infection+3 more
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina 1,200
Testing effectiveness (Phase 2)Study completedNCT00221650
What this trial is testing

Treatment of Chronic Hepatitis C With PEG Interferon alfa2a and Ribavirin in HIV-Infected Patients

Who this might be right for
HIV InfectionsHepatitis C, ChronicTreatment Failure
University Hospital, Bordeaux 17
Not applicableUnknownNCT03668288
What this trial is testing

Tolerance and Patients' Satisfaction With IGHy

Who this might be right for
Secondary or Primary Immunodeficiency
CHU de Reims 20
Testing effectiveness (Phase 2)Study completedNCT04030598
What this trial is testing

Assess the Clinical Efficacy of Donidalorsen (Also Known as IONIS-PKK-LRx and ISIS 721744) in Participants With Hereditary Angioedema

Who this might be right for
Hereditary Angioedema
Ionis Pharmaceuticals, Inc. 23
Not applicableStudy completedNCT03054181
What this trial is testing

Facilitated Immunoglobulin Administration Registry and Outcomes Study (FIGARO)

Who this might be right for
Primary ImmunodeficiencySecondary Immune Deficiency
GWT-TUD GmbH 156
Post-approval studies (Phase 4)Study completedNCT02711228
What this trial is testing

Study of Immune Deficiency Patients Treated With Subcutaneous Immunoglobulin (IgPro20, Hizentra®) on Weekly and Biweekly Schedules

Who this might be right for
Primary Immune DeficiencySecondary Immune Deficiency
CSL Behring 26
Not applicableStudy completedNCT00000744
What this trial is testing

A Randomized, Prospective, Double-Blind Study Comparing Fluconazole With Placebo for Primary and Secondary Prophylaxis of Mucosal Candidiasis in HIV-Infected Women

Who this might be right for
CandidiasisCandidiasis, EsophagealHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 400
Not applicableStudy completedNCT00517803
What this trial is testing

Micronutrient Supplemented Probiotic Yogurt for HIV/AIDS and Other Immunodeficiencies

Who this might be right for
HIV InfectionsCancer, Second Primary
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 24
Not applicableStudy completedNCT01414660
What this trial is testing

Evolution of Interleukin 7, Fat Mass and Metabolic Profile Before and After Transplantation

Who this might be right for
Immunodeficiency Secondary to Organ Transplantation
University Hospital, Lille 49
Not applicableStudy completedNCT04323176
What this trial is testing

2nd AC+: New Village Model

Who this might be right for
AgingHivLoneliness+1 more
University of California, San Diego 48
Large-scale testing (Phase 3)Looking for participantsNCT06980480
What this trial is testing

Gammagard Liquid (Immune Globulin Infusion, 10%) to Prevent Infections in Adults With Multiple Myeloma

Who this might be right for
Multiple MyelomaSecondary Immunodeficiency
Takeda 183
Not applicableStudy completedNCT03250845
What this trial is testing

Comparison of Multigam IV (5% vs. 10%) in Patients With an Immunodeficiency Secondary to a Hematological Disorder

Who this might be right for
Hematologic DiseasesSecondary Immune Deficiency
Universitaire Ziekenhuizen KU Leuven 30
Early research (Phase 1)Study completedNCT00092937
What this trial is testing

Use of Busulfan as Conditioning Agent for a Second Stem Cell Transplant

Who this might be right for
Granulomatous DiseaseChronic
National Institute of Allergy and Infectious Diseases (NIAID) 2
Not applicableNot Yet RecruitingNCT07189013
What this trial is testing

Assessing Patient Preference for Infusion Systems

Who this might be right for
Primary Immunodeficiencies (PID)Secondary Immunodeficiencies (SID)
KORU Medical Systems, Inc. 52
Large-scale testing (Phase 3)Study completedNCT02227238
What this trial is testing

Comparative Efficacy and Safety Study of Dolutegravir and Lopinavir/Ritonavir in Second-line Treatment

Who this might be right for
HIV Infections
ViiV Healthcare 627
Early research (Phase 1)Ended earlyNCT01249443
What this trial is testing

Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection

Who this might be right for
HIV InfectionRecurrent Anal CancerRecurrent Breast Cancer+31 more
AIDS Malignancy Consortium 17
Not applicableLooking for participantsNCT06821880
What this trial is testing

Developing a Patient-Reported Outcome (PRO) Screening Measure for Infections and Measuring Quality of Life in Hematological Patients With Secondary Immunodeficiency (SID) Across the Treatment Trajectory - The PRO SID Project

Who this might be right for
Chronic Lymphocytic Leukaemia (CLL)Multiple Myeloma (MM)Secondary Immunodeficiency (SID)
Medical University Innsbruck 120
Not applicableLooking for participantsNCT06659588
What this trial is testing

Study of Populations at Risk of Developing Chronic Hepatitis Linked to Chronic Enteric Virus Infection in Patients With Primary Immunodeficiency and Secondary Humoral Deficiency

Who this might be right for
Humoral Primary Immunodeficiencies (PIDs)Secondary Form of Humoral ImmunodeficienciesCombined Immunodeficiency (CID)+1 more
Assistance Publique - Hôpitaux de Paris 120
Testing effectiveness (Phase 2)WithdrawnNCT00008866
What this trial is testing

Effectiveness of Early or Delayed Addition of Hydroxyurea to a Three-Drug Anti-HIV Drug Combination Including Didanosine, in Advanced HIV Patients Who Failed a First or Second Anti-HIV Triple-Drug Therapy

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID)
Early research (Phase 1)Study completedNCT03960645
What this trial is testing

Study to Evaluate the Pharmacokinetics (PK), Safety, and Efficacy of B/F/TAF in Human Immunodeficiency Virus (HIV)-1 Infected, Virologically Suppressed, Pregnant Women in Their Second and Third Trimesters

Who this might be right for
HIV-1-infection
Gilead Sciences 62
Load More Results